
Keywords: allo-HSCT, allogeneic haematopoietic stem cell transplantation; NK, natural killer; KIR, killer inhibitory receptor; GvHD, graft-versus-host disease; haplo-HSCT, haploidentical haemopoietic stem cell transplantation; HLA, human leukocyte antigen; MHC, maj